APOE and Alzheimer disease: The combined effect of changes in these mechanisms means individuals heterozygous for the ε4 genotype of APOE have three times the risk of developing sporadic Alzheimer’s Disease (AD), increasing to 14 times the risk for homozygotes2,4.